HER2 + BREAST CANCER
Clinical trials for HER2 + BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2 + BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell combo targets Hard-to-Treat breast cancer
Disease control OngoingThis early-stage trial tests a new two-part treatment for people with advanced breast cancer that has not responded to standard therapies. Participants receive a single infusion of their own engineered immune cells (CLBR001) followed by cycles of a biologic drug (ABBV-461). The m…
Matched conditions: HER2 + BREAST CANCER
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Blood test could guide care for Long-Term breast cancer responders
Knowledge-focused OngoingThis study looks at 50 patients with HER2-positive metastatic breast cancer who have had a good response to anti-HER2 therapy for at least two years. Researchers will use a blood test called Signatera to check for tiny bits of cancer DNA. The goal is to learn if this test can hel…
Matched conditions: HER2 + BREAST CANCER
Sponsor: Nagoya City University • Aim: Knowledge-focused
Last updated May 17, 2026 00:51 UTC